LIWANLI Innovation (Taiwan) Performance
| 3054 Stock | TWD 24.90 0.45 1.84% |
LIWANLI Innovation has a performance score of 9 on a scale of 0 to 100. The company secures a Beta (Market Risk) of -0.0145, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning LIWANLI Innovation are expected to decrease at a much lower rate. During the bear market, LIWANLI Innovation is likely to outperform the market. LIWANLI Innovation currently secures a risk of 1.22%. Please verify LIWANLI Innovation Co jensen alpha, sortino ratio, maximum drawdown, as well as the relationship between the total risk alpha and treynor ratio , to decide if LIWANLI Innovation Co will be following its current price movements.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in LIWANLI Innovation Co are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, LIWANLI Innovation may actually be approaching a critical reversion point that can send shares even higher in February 2025. ...more
| Begin Period Cash Flow | 339 M | |
| Total Cashflows From Investing Activities | 46 M | |
| Free Cash Flow | -63.3 M |
LIWANLI |
LIWANLI Innovation Relative Risk vs. Return Landscape
If you would invest 2,280 in LIWANLI Innovation Co on October 11, 2024 and sell it today you would earn a total of 210.00 from holding LIWANLI Innovation Co or generate 9.21% return on investment over 90 days. LIWANLI Innovation Co is generating 0.1472% of daily returns and assumes 1.2169% volatility on return distribution over the 90 days horizon. Simply put, 10% of stocks are less volatile than LIWANLI, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
LIWANLI Innovation Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for LIWANLI Innovation's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as LIWANLI Innovation Co, and traders can use it to determine the average amount a LIWANLI Innovation's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.121
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | 3054 | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.22 actual daily | 10 90% of assets are more volatile |
Expected Return
| 0.15 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average LIWANLI Innovation is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of LIWANLI Innovation by adding it to a well-diversified portfolio.
LIWANLI Innovation Fundamentals Growth
LIWANLI Stock prices reflect investors' perceptions of the future prospects and financial health of LIWANLI Innovation, and LIWANLI Innovation fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on LIWANLI Stock performance.
| Return On Equity | -0.12 | |||
| Return On Asset | -0.0274 | |||
| Profit Margin | (2.88) % | |||
| Operating Margin | (1.15) % | |||
| Current Valuation | 1.2 B | |||
| Shares Outstanding | 80.65 M | |||
| Price To Earning | 156.10 X | |||
| Price To Book | 2.04 X | |||
| Price To Sales | 45.98 X | |||
| Revenue | 47.81 M | |||
| EBITDA | 65.26 M | |||
| Cash And Equivalents | 661.45 M | |||
| Cash Per Share | 7.93 X | |||
| Total Debt | 2.13 M | |||
| Debt To Equity | 0 % | |||
| Book Value Per Share | 9.56 X | |||
| Cash Flow From Operations | (61.13 M) | |||
| Earnings Per Share | 0.18 X | |||
| Total Asset | 947.9 M | |||
| Retained Earnings | 18 M | |||
| Current Asset | 794 M | |||
| Current Liabilities | 409 M | |||
About LIWANLI Innovation Performance
Evaluating LIWANLI Innovation's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if LIWANLI Innovation has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if LIWANLI Innovation has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
LIWANLI Innovation Co., Ltd. operates in the biomedical science industry. LIWANLI Innovation Co., Ltd. was founded in 1991 and is based in New Taipei City, Taiwan. LIWANLI INNOVATION operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan Stock Exchange.Things to note about LIWANLI Innovation performance evaluation
Checking the ongoing alerts about LIWANLI Innovation for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for LIWANLI Innovation help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| LIWANLI Innovation Co has accumulated about 661.45 M in cash with (61.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.93. | |
| Roughly 82.0% of the company shares are owned by insiders or employees |
- Analyzing LIWANLI Innovation's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether LIWANLI Innovation's stock is overvalued or undervalued compared to its peers.
- Examining LIWANLI Innovation's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating LIWANLI Innovation's management team can have a significant impact on its success or failure. Reviewing the track record and experience of LIWANLI Innovation's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of LIWANLI Innovation's stock. These opinions can provide insight into LIWANLI Innovation's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for LIWANLI Stock Analysis
When running LIWANLI Innovation's price analysis, check to measure LIWANLI Innovation's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LIWANLI Innovation is operating at the current time. Most of LIWANLI Innovation's value examination focuses on studying past and present price action to predict the probability of LIWANLI Innovation's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LIWANLI Innovation's price. Additionally, you may evaluate how the addition of LIWANLI Innovation to your portfolios can decrease your overall portfolio volatility.